{"id":"W2334177588","doi":"10.1016/j.jpain.2016.01.397","title":"(420) NEO6860, a novel modality selective TRPV1 antagonist: results from a phase I, double-blind, placebo-controlled study in healthy subjects","year":2016,"lang":"en","type":"article","venue":"Journal of Pain","topic":"Ion Channels and Receptors","field":"Neuroscience","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"NEOMED Institute","funders":"","keywords":"Medicine; Cmax; Placebo; Adverse effect; Discontinuation; Pharmacokinetics; TRPV1; Pharmacodynamics; Antagonist; Anesthesia; Capsaicin; Pharmacology; Gastroenterology; Internal medicine; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005492951,0.0002652325,0.0007815412,0.0003916004,0.0001731682,0.00007758693,0.000402021,0.0001236633,0.00003691316],"category_scores_gemma":[0.002951754,0.000155879,0.000230433,0.0005312476,0.00008492648,0.0003373637,0.00005351176,0.0004921189,0.00001209292],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003110884,"about_ca_system_score_gemma":0.0004448566,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005080608,"about_ca_topic_score_gemma":0.0005572931,"domain_scores_codex":[0.9955047,0.001495781,0.001334427,0.0004803419,0.0006982528,0.0004864326],"domain_scores_gemma":[0.9957097,0.002533396,0.001097149,0.0002003281,0.0001807812,0.0002786839],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6570997,0.006335954,0.0007606663,0.000008481745,0.00008222402,0.0003336322,0.005528718,0.0001097646,0.3260972,0.00003034637,0.0006944537,0.002918957],"study_design_scores_gemma":[0.8689874,0.008688556,0.0008011603,0.0002228531,0.00007213031,0.0000740546,0.001091039,0.002049611,0.1164831,0.0006156394,0.0004570799,0.000457346],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913666,0.00003838646,0.00194106,0.004171687,0.0009915438,0.001217818,0.000102056,0.00002195953,0.0001488511],"genre_scores_gemma":[0.9985315,0.00004160885,0.0001048661,0.0005388631,0.0005466429,0.00002543403,0.000001058394,0.00002463602,0.0001854501],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2118878,"threshold_uncertainty_score":0.6356561,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07433926424854742,"score_gpt":0.3518135080970745,"score_spread":0.277474243848527,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}